20 mg Mitoxantrone Injection USP is a medication used in cancer treatment, particularly in the management of certain types of leukemia, lymphoma, and advanced prostate cancer. Mitoxantrone is a type of chemotherapy drug classified as an anthracycline. It works by interfering with the DNA inside cancer cells, preventing them from dividing and multiplying. This action helps to slow down or stop the growth and spread of cancer cells. 20 mg Mitoxantrone Injection USP is usually administered as an intravenous (IV) infusion by a healthcare professional in a hospital or clinic setting.
Form - Liquid